HIF3A and cancer: In these models, changing levels of IPAs are one of a suite of induced changes, including altered systemic effects, and exocrine-endocrine signaling, that interact with genetic activation of PDAC typically induced simultaneously in many cancer precursor cells, rather than the rare clonal initiating events seen in humans.